HPV 18 and cervical adenocarcinomas

Area of Science:

• Oncology
• Virology
• Gynecology

Background:

• Previous studies suggest a link between Human Papillomavirus (HPV) 18 and cervical adenocarcinoma.
• The prevalence of specific HPV types in cervical adenocarcinoma requires further investigation, particularly in different geographical regions.

Purpose of the Study:

• To determine the presence and prevalence of HPV 16 and HPV 18 in cervical adenocarcinoma biopsies from Northern Sweden.
• To explore potential associations between HPV status, menopausal status, and previous cytology findings in patients with cervical adenocarcinoma.

Main Methods:

• Polymerase Chain Reaction (PCR) was employed to detect HPV DNA in paraffin-embedded cervical adenocarcinoma tissue samples.
• A total of 26 cases were analyzed for the presence of HPV 16 and HPV 18 DNA.

Main Results:

• HPV DNA was detected in 42% (11/26) of the cervical adenocarcinoma cases.
• HPV 18 was identified in 27% (7/26) and HPV 16 in 15% (4/26) of the cases.
• A significant association was observed between HPV positivity and premenopausal status (9/13 cases) compared to postmenopausal status (2/13 cases) (p < 0.015).

Conclusions:

• The findings confirm the presence of HPV 16 and 18 in cervical adenocarcinoma in Northern Sweden.
• The higher prevalence of HPV in premenopausal women suggests a potential role in the epidemiology of cervical adenocarcinoma.
• Further research is warranted to elucidate the specific mechanisms and implications of HPV in cervical adenocarcinoma development.